Simulation of long-term lecanemab treatment effect on Alzheimer's disease progression
{{output}}
Introduction: Anti-amyloid therapies such as lecanemab have demonstrated statistically significant slowing of decline on the Clinical Dementia Rating-Sum of Boxes (CDR-SB) in patients with early Alzheimer's disease (AD) in pivot... ...
